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Background: Specific recognition of phosphotyrosine-containing protein
segments by Src homology 2 (SH2) and phosphotyrosine-binding (PTB)
domains plays an important role in intracellular signal transduction. Although
many SH2/PTB-domain-containing receptor–peptide complex structures have
been solved, little has been done to study the problem computationally.
Prediction of the binding geometry and the binding constant of any
peptide–protein pair is an extremely important problem.
Results: A procedure to predict binding energies of phosphotyrosine-
containing peptides with SH2/PTB domains was developed. The average
deviation between experimentally measured binding energies and theoretical
evaluations was 1.8 kcal/mol. Binding states of unphosphorylated peptides
were also predicted reasonably well. Ab initio predictions of binding geometry
of fully flexible peptides correctly identified conformations of two pentapeptides
and a hexapeptide complexed with a v-Src SH2 domain receptor with root
mean square deviations (rmsds) of 0.3 Å, 1.2 Å and 1.5 Å, respectively. 
Conclusions: The binding energies of phosphotyrosine-containing complexes
can be effectively predicted using the procedure developed here. It was also
possible to predict the bound conformations of flexible short peptides correctly
from random starting conformations.
Introduction
Specific recognition of phosphotyrosine-containing protein
segments by Src homology 2 (SH2) and phosphotyrosine-
binding (PTB) domains (also known as phosphotyrosine
interaction, PI, domains) plays an important role in intra-
cellular signal transduction. This type of interaction leads
to a broad range of cellular processes, such as growth, pro-
liferation, differentiation, mitogenesis and transformation
[1–3]. SH2-domain-containing proteins can either modu-
late enzymatic activities of downstream signal-transduction
events or act as adaptor molecules in protein–protein inter-
action. PTB domains serve as alternative binding domains
and recruit additional signaling proteins to the vicinity of
an activated receptor [4–6]. SH2 and PTB domains have
attracted considerable interest in recent years; more than
20 structures of peptide–receptor complexes have been
published since the first structure by Waksman et al. [7].
The key property of the SH2-modulation mechanism is
that phosphorylation/dephosphorylation of a specific tyro-
sine residue of the peptide ligand acts as an on/off switch
[1]. It was experimentally demonstrated that phosphoryla-
tion plays a critical role in association of an SH2–EGFR
complex (epidermal growth factor receptor) [8], an
SH2–FAK complex (focal adhesion kinase) [8]; a p85α
SH2-containing complex [9,10], a Cγ1 Syk SH2-containing
complex [11], a Syk C-terminal SH2-containing complex
[12], p56lck SH2 containing complexes [13–15], a Src
Hck–quercetin complex [16], as well as other complexes
[17,18]. The recently discovered PTB domains do not
always require phosphorylation for binding [1,4], but phos-
phorylation usually increases the binding affinity. For the
Shc adaptor protein the increase was estimated as at least
7.5 kcal/mol [19]; for the insulin receptor substrate-1 (IRS-
1) specific peptide, the increase was estimated to be at least
4.1 kcal/mol (a factor of 1000, Zhou et al. [20]; MM Zhou,
personal communication). The X11 PTB domain, however,
binds both phosphorylated and unphosphorylated peptides
rather strongly with Kds of 8.3 µM and 4.6 µM, respectively,
and phosphorylation decreases binding by 0.4 kcal/mol [21].
These complex behaviors require a quantitative explana-
tion. Little has been done, however, to study the problem
computationally. The computational analysis is compli-
cated by the magnitude of conformational rearrangement
of the binding proteins, lack of adequate description of
the unbound states and the inaccuracies of the force-field
parameters and partial charges. Two properties of these
complexes, however, make theoretical investigation feasi-
ble. First, it was experimentally demonstrated that short
peptides from the binding segments could mimic specific
complexes with the SH2 domains [11,15]. Secondly, it has
been shown that SH2 domains do not undergo large con-
formational changes upon association [7,22,23].
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In this paper we address two computational problems: pre-
diction of the binding energy of both phosphorylated and
unphosphorylated peptides given the geometry of the
complex, and prediction of the association geometry of a
fully flexible peptide to its receptor.
Theoretical binding energy evaluation is a complex and,
as yet, unsolved problem [24–26]. Some methods use
sophisticated and computationally costly approaches, such
as molecular dynamics (MD) [27], free energy perturba-
tion (FEP) and thermodynamic integration (TI) [28], the
protein dipoles Langevin dipoles (PDLD) model and
linear-response approximation (LRA) [29]. Other methods
use simplified binding functions that attempt to capture
the major contributions to the binding energy [24,30,31],
such as polar and apolar contributions [32], entropy loss of
the ligand [33,34] and surface complementarity [35]. In
general, fast and simple evaluations of binding energy are
essential for a large scale screening of compound data-
banks [36]. The evaluation scheme used in this work was
similar to the one used by Novotny and coworkers
[33,34,37] with the exception of two modifications. First,
we use a rigorous boundary-element evaluation of the
electrostatic components of the interaction. Second, we
took advantage of a rigorous sidechain-refinement proce-
dure using optimal-bias Monte Carlo minimization
(OBMCM, also known as biased probability Monte Carlo
[38]), that improves the accuracy of the electrostatic con-
tribution (see the Results and discussion section). 
Flexible docking of peptides to their protein receptors
remains an unsolved problem [39–41]. Even a single
peptide in isolation has too many degrees of freedom for a
reliable prediction. To avoid this difficulty, ligands are
usually considered to be rigid or are constructed incremen-
tally from rigid parts [30,42]. The OBMCM algorithm [38]
for efficient global optimization of a peptide was shown to
predict the conformation of isolated peptides [43]. Here
we demonstrate that this algorithm can be combined with
pseudo-Brownian random moves [44] to allow efficient
sampling of both the energy landscape of a continuously
flexible peptide, as well as peptide interaction with its
receptor represented by a set of grid of potentials [45,46].
In this paper we describe the binding energy evaluation of
12 phosphopeptide–receptor complexes. Comparison of
the results between unrefined and refined complex struc-
tures suggests the sidechain-refinement procedure is
important in the binding affinity evaluation. The pre-
dicted energies for phosphorylated and unphosphorylated
peptides explain most of the experimental measurements
and suggest that similar calculations can be used to evalu-
ate the binding and role of phosphorylation in uncharac-
terized peptide–receptor complexes. Furthermore, the
bound conformation of three short peptides was predicted
with reasonable accuracy.
Results and discussion
Binding energy function
Models of 12 selected phosphorylated complexes (Table 1)
were built using the regularization procedure followed by
the sidechain-refinement procedure (see the Materials and
methods section). The sidechain-refinement procedure
resolves clashes after hydrogen atoms have been added to a
structure and corrects geometrical inaccuracies and ambi-
guities. For example, some interface residues in the p56lck
complex (PDB code 1LKK) have dual sidechain conforma-
tions [47]; the peptide ends in a Cγ1 Syk complex (2PLD)
are undefined [48]; part of the ligand-binding loop in the c-
Src complex 1SHD is disordered [8]; and backbone
peptide bonds deviate significantly from both cis and trans
conformations in the Shc-adaptor complex 1TCE [49]. The
refinement procedure is expected to eliminate clashes,
thus optimizing electrostatic contacts between the two
interacting domains [50].
We applied the following empirical binding energy func-
tion (see the Materials and methods section) to the refined
flexible peptide–receptor complexes in Table 1:
∆Gcalc = ∆GBEP(ε) + s∆A – T∆S + C (1)
Where ∆GBEP(ε) is the electrostatic free energy change, ε
is the dielectric constant, s is the surface tension, ∆A is the
change of solvent accessible area, T is room temperature,
∆S is the entropy term evaluated via the number of ligand
free backbone torsions and the relative accessibility
change of the interface sidechains (see the Materials and
methods section), and C is a constant. The dielectric con-
stant ε, surface tension s, and the constant C can be
adjusted to partially absorb other missing contributions.
For various combinations of ε and C, the optimal surface-
tension constants s were determined by minimizing the
average deviation between experimental measurements
and theoretical predictions, 〈|∆Gcalc – ∆Gexp|〉, on the set of
phosphorylated complexes as discussed in the next
section. During the above minimization process, ε values
above 4 and C values ranging from 0–30 kcal/mol were
examined. The best combination was found to be ε = 24,
s = 19.0 cal/mol/Å2, and C = 5.0 kcal/mol.
The experimental binding data have considerable inaccura-
cies: about 1.1 kcal/mol for a p56lck complex (1LCK) [14],
1.0 kcal/mol for the Cγ1 Syk complex [48], and possibly
even larger for another p56lck complex (1LCJ) [13]
(Table 1). Furthermore, the binding data might also be sen-
sitive to solution conditions, such as pH and salt concentra-
tion [51]. We assumed 1.0 kcal/mol to be the experimental
error, and found that many combinations of the parameters
with ε ≥ 9, C ≤ 14 kcal/mol, and 14.6 ≤ s ≤ 27.9 cal/mol/Å2
can all explain the available data accurately within
1 kcal/mol. The dependence of the performance of
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binding prediction to the binding parameters is also dis-
cussed in a separate work (M Schapira and R.A., unpub-
lished observations).
Binding energy calculation for phosphorylated complexes
Binding energies for phosphorylated complexes calculated
using the above optimal parameters and the corresponding
experimental data are listed in Table 2 and plotted in
Figure 1 (filled circles) for comparison. The average devia-
tion between the two data sets is 1.8 kcal/mol with a high
correlation coefficient of 0.87. Underestimation of the
binding affinity in an Shc SH2-domain-containing model
(1TCE) might be attributable to the problematic ligand
backbone coordinates [49]. 
Evaluation of binding energies on initially regularized but
unrefined models resulted in a lower correlation coefficient
of 0.71 (open circles in Figure 1), even when the three
parameters were readjusted using the unrefined models
themselves. On average, the electrostatic contribution to
the binding energies of the studied complexes was modi-
fied by 2.3 kcal/mol after the sidechain refinement, which
mainly led to the improved fit.
We analyzed the effect of several alternative forms of the
binding energy terms on the prediction accuracy. After
each modification the parameters were re-optimized to
maximize the correlation. When the entropy contribution
to binding was calculated as Ntorsion*0.6 kcal/mol, the cor-
relation dropped from 0.87 to 0.74. When the molecular
surface area [52] (the contact area of the probe sphere) was
used instead of the solvent-accessible area (the center of
the probe sphere) to calculate the surface contribution, as
recommended by Tunon et al. [53] and Novotny et al. [34],
the optimal correlation remained unchanged. The surface-
based atomic solvation parameter method [43,54] com-
bined with the Coulomb evaluation of the intermolecular
interactions slightly reduced the correlation coefficient to
0.82. The current set is too small to make definite conclu-
sions about the optimal choice of terms. A more system-
atic analysis of binding energy terms, based on a larger set
of complexes, will be published elsewhere (M Schapira
and R.A., unpublished observations).
Binding energy prediction for unphosphorylated complexes
Is the accuracy of the above algorithm for binding energy
evaluation sufficient to predict whether a given peptide
will stay bound or disassociate after dephosphorylation?
To answer this question, we performed a series of calcula-
tions on unphosphorylated complexes. Because structural
information for the unphosphorylated complexes is gener-
ally not available, their initial models were derived from
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Table 1
Protein–phosphopeptide complexes and their experimentally determined binding energies.
Complex
(PDB code) Receptor Ligand sequence Kd (µM) ∆Gexp* (kcal/mol)
1IRS Insulin receptor substrate-1 PTB domain LVIAGNPApYRS 6 [20] –7.17
1LCJ p56lck tyrosine kinase SH2 domain EPQpYEEIPIYL 0.001 [13], 0.0035–0.0063† –7.93‡
1LCK p56lck tyrosine kinase SH2 domain EGQpYQPQPA 2.92§, 20† –7.02#
1LKK p56lck tyrosine kinase SH2 domain Ac-pYEEI 0.14¶ –9.41
1LKL p56lck tyrosine kinase SH2 domain Ac-pYEEG 1.54¶ –7.98
1PIC Phosphatidylinositol 3-kinase P85α SH2 domain Ac-pYVPM 0.058 [10] –9.93
2PLD Phospholipase Cγ1 Syk SH2 domain DNDpYIIPLPDPK 0.1-0.5 [48] –9.13#
1SHA v-Src tyrosine kinase SH2 domain pYVPML 5.9 [23] –7.11
1SHC Shc adaptor protein PTB domain HIIENPQpYFSDA 0.053 [19,56] –9.99
1SHD c-Src tyrosine kinase SH2 domain Ac-pYEEI ~0.1 [8] ~–9.61
1SPS v-Src tyrosine kinase SH2 domain EPQpYEEIPIYL 0.003-0.006 [57], 0.2 [23] –9.11¥
1TCE Shc adaptor protein SH2 domain GHDGLpYQGLSTATK 50 [49] –5.90
Complex
(PDB code) Receptor Ligand sequence Relative binding affinity ∆∆Gexp (kcal/mol)
1AYA Tyrosine phosphatase Syp SH2 domain SVLpYTAVQPNE 0.08** 0.55**
1AYB Tyrosine phosphatase Syp SH2 domain SPGEpYVNIEF 0.2** 0.0**
1AYC Tyrosine phosphatase Syp SH2 domain DGGpYMDMSKDE < 0.003** > 2.50**
*∆Gexp is calculated from Kd value using ∆Gexp = RTlnKd, where R is the
gas constant and T is room temperature. †From Table 2 in [15]; Kds were
measured using surface plasmon resonance (SPR). ‡The binding energy
was derived from measurements for 1LCK [14], as well as from the ID50
values determined for these two ligands (Table 1 in [15]). The data for
1LCK were determined using isothermal titration calorimetry (ITC), which
directly measures the heat of reaction associated with binding [1,69].
ITC avoids the artifact that can arise when the target peptides are
immobilized in the SPR method, which can lead to higher determined
affinity. ID50 values used for 1LCJ and 1LCK were1.8 µM and 8.2 µM,
respectively. §From Table 1 in [17]; Kd was measured using the ITC
method. #The average value of the measurements was used. ¶Kd for
1LKL was derived from 1LKK, because its binding was 11-fold weaker
[47]. ¥Kd value determined in [23] was used as suggested by Waksman
et al. [23]. **From Figure 1 in [22]. The binding energy was compiled
from data presented by Case et al. [70]. 1AYB was used as the
reference ligand, whose ∆∆Gexp is defined to be 0 kcal/mol.
the corresponding PDB entries by omitting the phosphate
groups. The initial models were then refined using the
same procedure as for the phosphorylated proteins.
The predictions for the unphosphorylated ligands using
the previous optimal binding function are shown in
Figure 2. For those SH2-domain-containing complexes
whose experimental binding data are not available, it is
generally believed that they do not bind or bind only
weakly. For two p56lck complexes (1LCJ [13] and 1LCK
[14]), a Shc SH2 domain-containing complex (1TCE [49]),
a Grb SH2 domain-containing complex (1TZE [55]), two
v-Src complexes (1SHA and 1SHB [7]) and two Syp com-
plexes (1AYA and 1AYC [22]), the unphosphorylated pep-
tides were predicted to be in the free form. Other
SH2-domain-containing complexes were predicted to be
weakly bound. (A 50 µM dissociation value was used for
distinguishing weakly bound from bound states.) The
affinities of the unphosphorylated complexes were cor-
rectly predicted to be much weaker than the phosphory-
lated ones, with an average gap of 6.6 kcal/mol.
The binding energy differences are more variable for the
PTB domain-containing complexes and these variations
were correctly captured using our method. The method
correctly predicted a 6 kcal/mol increase of the 11-residue
peptide to the IRS-1 PTB domain [20] and the 13-residue
peptide to the Shc PTB domain [56] upon phosphoryla-
tion. In contrast, the evaluation suggested only
0.1 kcal/mol difference between the phosphorylated and
unphosphorylated models in the X11 PTB domain-con-
taining complex (1AQC [21]), which agrees well with the
0.4 kcal/mol experimental measurement.
These results are encouraging as all the unphosphorylated
binding energies were evaluated using parameters that
were derived purely on the basis of the phosphorylated
structures listed in Table 1, without prior knowledge of
any binding energies on unphosphorylated peptides. The
fact that on average the electrostatic contribution accounts
for 5.5 kcal/mol out of the 6.6 kcal/mol (83%) binding
energy enhancement after phosphorylation agrees with
our qualitative understanding. Eight complexes, however,
were predicted to have binding energy lower than
–2 kcal/mol, which is the error of the empirical binding
function. These numbers indicate that the binding energy
for the unphosphorylated models can be overestimated
using this method.
Ab initio ligand docking simulations
As individual receptor structures and complex structures
are both available for certain targets in our complex set, we
also made an attempt to predict not only the binding ener-
gies but also the ligand conformation ab initio given only
minimal information about the approximate location of the
receptor-binding site. The candidates for our docking sim-
ulations were three v-Src complexes (1SHA, 1SHB [7] and
1SPS [57]) and three Syp complexes (1AYA, 1AYB and
1AYC [22]). These were the only structures of the SH2
family that had both isolated SH2 domain structures and
complex structures deposited in the Brookhaven PDB.
Simulations were performed for the six structures and the
1IRS complex [20] model (Table 3), where the receptor
structures were taken from the refined models described
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Table 2
Theoretical estimations of binding energies of the selected
phosphorylated complex set.
Complex ∆Gel s∆Α –T∆S ∆Gcalc ∆Gexp
(PDB code)(kcal/mol) (kcal/mol) (kcal/mol) (kcal/mol) (kcal/mol)
1IRS –4.37 –23.85 15.99 –7.22 –7.17
1LCJ –4.16 –22.98 15.69 –6.45 –7.93
1LCK –6.26 –19.47 13.68 –7.04 –7.02
1LKK –5.55 –16.03 8.07 –8.51 –9.41
1LKL –6.91 –15.31 8.94 –8.28 –7.98
1PIC –4.78 –21.70 9.40 –12.08 –9.93
2PLD –4.43 –25.93 16.12 –9.24 –7.11
1SHA –4.70 –16.30 8.65 –7.35 –9.99
1SHC –6.19 –33.69 20.43 –14.45 –9.99
1SHD –9.88 –16.02 8.98 –11.92 –9.61
1SPS –10.93 –21.24 17.48 –9.69 –9.11
1TCE 1.92 –23.46 19.64 3.09 –5.90
∆∆Gel s∆∆Α –T∆∆S ∆∆Gcalc ∆∆Gexp
Complex* (kcal/mol) (kcal/mol) (kcal/mol) (kcal/mol) (kcal/mol)
1AYA 3.84 1.91 –1.85 3.90 0.55
1AYC 5.24 8.65 –1.57 12.32 > 2.50
Figure 1
Comparison of theoretical predictions with experimental measurements
using the models before (open circles) and after (filled circles) the
interface sidechain-refinement procedure.
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before. Due to the fact that the C terminus of the 1SPS
ligand interacts with another receptor domain (which com-
plicates the calculation and interpretation), a shorter
peptide Ac-PQpYEEI-NH2 was used in the docking simu-
lation of 1SPS as suggested by one of our referees.
The prediction was performed in two major steps as recom-
mended previously [46,58] (see the Materials and methods
section). The first step involves docking of fully flexible,
full atom model of the peptide into the set of receptor grid
potentials. The grid potentials are precalculated potential
fields generated by the rigid receptor, and enabled us to
dramatically improve the computational efficiency of the
interaction energy [45,46]. A combination of OBMCM [38]
and pseudo-Brownian moves was used to sample the con-
formational space. The first step resulted in a set of about
40 low-energy conformations. In the second step, all of the
low-energy solutions were refined with the explicit recep-
tor using the OBMCM interface sidechain-refinement pro-
cedure (see the Materials and methods section) and sorted
according to the final energy values.
In a 1SHA model simulation, the lowest energy conforma-
tion found by the grid potential folding simulation was
already very close to the crystallographic conformation
(rmsd ~1.7 Å). After the global OBMCM refinement of the
40 low-energy conformations, the near-native solution
remained the most energetically favoured. Furthermore,
the backbone rmsd from the crystallographic structure
dropped to the even lower value of only 0.3 Å after the
refinement. The 1SHB model simulation illustrated the
power and the importance of the OBMCM sidechain-
refinement step. After the initial grid docking, two near-
native conformations with rmsd less than 2 Å were ranked
11th and 30th, respectively. The lowest energy conforma-
tion had an rmsd of 4.5 Å, and solution 24 had an rmsd of
2.9 Å. The OBMCM refinement of all the solutions
resulted in the rank 24 solution being improved, however,
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Figure 2
Binding energy predictions of
unphosphorylated complexes. The proteins
1TCE [49], 1TZE [55], 1LCJ [13], 1SHB [7],
1AYA [22], 1SHA [7], 1LCK [14] and 1AYC
[22] were predicted to be in the unbound
form, and 1X11 and 1AQC [21] were
correctly predicted to be strongly bound (the
experimentally measured binding energies are
–8.87 kcal/mol for 1X11 and –6.98 kcal/mol
for 1AQC). Other complexes were predicted
to be weakly bound, if a dissociation constant
of 50 µM was used as the boundary between
weakly bound complexes and the more
strongly bound ones.
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Table 3
Results of docking of six peptides to their receptors taken
from the complex models.
Complex Peptide Emin rmsdmin Eclosest rmsdclosest
(PDB code) length (kcal/mol) (Å) (kcal/mol) (Å)
1SHA* 5 –1231 0.3 –1231 0.3
1SHB* 5 –1347 1.2 –1347 1.2
1SPS* 6 –1263 1.5 –1253 1.2
1IRS 11 –1358 3.9 –1317 3.1
1AYA 11 –1240 21.1 –1236 6.1
1AYB 12 –1222 15.9 –1202 13.3
1AYC 11 –1349 7.0 –1296 3.3
*The pentapeptide conformation could be predicted without a tether
being attached to the phosphorus atom in the phosphate group. Emin is
the energy of the lowest conformation found by the docking simulation,
and rmsdmin is the rmsd between the lowest energy ligand backbone
conformation and its native conformation. Eclosest is the energy of the
closest-to-native conformation found, and rmsdclosest is the rmsd
between this conformation and the native conformation.
to the most energetically favored conformation, with a
backbone rmsd of 1.2 Å to the crystallographic structure.
A similar result was obtained for the high-affinity hexa-
peptide (1SPS entry) simulation. The initial grid docking
found a conformation with an rmsd of 1.0 as rank seven.
The lowest energy conformation had an rmsd of 9.1 Å, and
the rank six conformation had an rmsd of 2.4 Å. The
OBMCM refinement of all the retained conformations
brought the rank six solution to the best energy conforma-
tion with a backbone rmsd of 1.5 Å. The rank seven con-
formation was moved to rank four with only a slightly
increased rmsd of 1.2 Å (compared to the initial 1.0 Å).
The crystal structures of the complexes and the predicted
ligand conformations of 1SHA, 1SHB, and 1SPS are
shown in Figure 3.
We also applied the same procedure to longer peptides
(around 11 residues) in the three Syk complexes and the
IRS-1 complex. These peptides have twice the number of
free variables and we could not find sampling conditions
that led to the correct predictions. After a tether was set
between a single phosphorus atom of the phosphate group
and the corresponding location in a binding pocket,
however, the sampling space was reduced. The simula-
tions found the best near-native conformations with rmsd
about 3 Å for the complex 1IRS and 1AYC, although these
conformations were energetically too high to be recognized
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Figure 3
(a) Superposition of three crystal structures of
the Src SH2 domain with different peptides
(1SHA, 1SHB and 1SPS). The molecular
surface of SH2 domain is colored by
electrostatic potentials calculated with REBEL
algorithm [46]. The peptide ligands in
complexes 1SHA, 1SHB and 1SPS are red,
green and white, respectively. (b) Ab initio
prediction of ligand conformation for 1SHA
[7]. (c) Ab initio prediction of ligand
conformation for 1SHB [7]. (d) Ab initio
prediction of ligand conformation for 1SPS
[57]. The green sticks present the
experimentally determined ligand structures,
the blue wires represent the ligand
conformations identified by the ab initio
folding within the grid potentials, which was
later refined in the ECEPP/3 [64–66]
forcefield to produce the final conformations
(the white sticks).
by the prediction. It should be noted that a single tether to
the phosphate atom is a biologically sensible restraint and
still leaves a lot of room for backbone rearrangements —
for example, backbone rmsd values up to 17 Å were found
in the simulation stack.
Docking a peptide into an uncomplexed receptor struc-
ture is a difficult task because of the conformational
changes that are induced upon complex formation. We
found that tethering only the phosphate group to its
binding pocket was sufficient for successful docking of
the rest of the peptides into experimentally solved
uncomplexed SH2 structures (1SPR receptor for peptides
from 1SHA, 1SHB [7] and 1SPS [57]; and 1AYD receptor
for peptides from 1AYA, 1AYB and 1AYC [22]). It
appeared that the correct conformation of the short pep-
tides was not found primarily because of insufficient sam-
pling, rather than higher interaction energy with the
deformed receptor. After a single tether was imposed on
the phosphorus atom and the binding pocket, the correct
folding of the rest of a peptide in the grid potentials
occurred rather quickly (Table 4). The peptides from the
1SHA complex, 1SHB complex, and the 1SPS complex
folded into the expected conformations (the backbone
rmsd was around 2.0 Å) in the field of the isolated SH2
domain from the 1SPR entry. Docking of the long pep-
tides into the isolated receptor structure (1AYD) resulted
in larger deviations than using the receptor structures of
the refined complexes.
The ab initio docking simulation of the three short pep-
tides performed remarkably well, given the giant size of
the conformational space and the lack of single clear
binding groove at the receptor. This work supports the
previous finding that the interface sidechain refinement
significantly improves the recognition of a correct confor-
mation among false positives [46,58]. A realistic ligand
simulation with the free receptor conformation 1SPR was
more challenging but was still successfully carried out
with the aid of a single tether imposed between the phos-
phate group and its binding site. The difficulties of simu-
lating docking for the long peptides were a result of both
insufficient conformational sampling and an inaccurate
force field, as the near-native conformations sometimes
had lower energy than the lowest-energy solutions found
by grid sampling and sometimes had higher energy than
those of other refined solutions.
Unlike any previous docking simulation (e.g. [59]), here
we considered fully flexible peptide ligand models and
completely random starting peptide conformations with
rmsd values up to 20 Å. Figure 4 shows some snapshots of
the 1SHA pentapeptide simulation and illustrates a wide
sampling range of the procedure. Quicktime movies of
1SHA, 1SHB, and 1SPS docking simulations are available
at the following URL: http://saturn.med.nyu.edu/groups/
AbagyanLab/sh2/.
Conclusions
In this work, an empirical binding energy that considers
accurate electrostatic contributions, hydrophobic effects
and configurational entropy changes has been applied to
analyze the association of SH2/PTB domains with their
specific phosphotyrosyl peptide ligands. The experimen-
tally measured binding energies of phosphopeptides were
accurately reproduced, within 1.8 kcal/mol (Figure 1), and
the complex pattern of the association states of unphos-
phorylated peptide ligands was predicted correctly in most
cases (Figure 2). Even such a subtle phenomenon as dif-
ferent magnitudes of binding enhancement upon phos-
phorylation in different complexes can be predicted
reasonably well using the proposed algorithm.
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Table 4
Results of restrained peptide docking to the peptide-free SH2
domains.
Peptide Emin rmsdmin Eclosest rmsdclosest
Complex length (kcal/mol) (Å) (kcal/mol) (Å)
1SHA 5 –1197 2.0 –1164 1.4
1SHB 5 –1311 1.3 –1311 1.3
1SPS 6 –1172 1.2 –1156 1.1
1AYA 11 –1260 18.9 –1230 13.9
1AYB 12 –1264 12.2 –1260 11.6
1AYC 11 –1336 20.8 –1291 14.7
Figure 4
Snapshots of an ab initio folding simulation of the 1SHA [7]
pentapeptide ligand using grid potentials. The receptor SH2 domain is
shown as a molecular surface, and five representative ligand
conformations sampled by the simulation are drawn as sticks. The
parameters in the parentheses show both the energy and the rmsd of the
corresponding conformations. The best conformation, with an rmsd of
1.7 Å, was also the lowest energy conformation in the simulation stack.
The native binding geometries of some protein–peptide
complexes were correctly predicted ab initio from random
initial conformations, that had rmsd values from the correct
position as large as 20 Å and their internal geometry fully
randomized (Figure 4)! It was demonstrated that a recently
developed two-step energy optimization procedure, con-
sisting of grid potential sampling followed by interface
refinement, could predict the binding modes of two pen-
tapeptides and a hexapeptide with 1 Å accuracy (Figure 3).
Predictions using longer peptides and/or the uncomplexed
conformations of the receptors proved to be more difficult,
but a minimal experimental restraint (such as the location
of the phosphate group) was sufficient to make a near-
correct prediction. This algorithm could be useful for pre-
dicting the geometry and energetics of binding for new, as
yet uncharacterized interactions between protein domains
involved in signal transduction.
Materials and methods
Peptide–receptor complexes studied
In total, 21 structures were selected for this study. They are X11 PTB
domain-containing complexes (1AQC and 1X11 [21]), Syp SH2
domain-containing complexes (1AYA, 1AYB, and 1AYC [22]), a Syk
C-terminal SH2 domain-containing complex (1CSZ [12]), Src SH2
domain-containing complexes (1HCT [60], 1SHA, 1SHB [7], 1SHD [8],
and 1SPS [57]), IRS-1 domain-containing complex (1IRS [20]), p56lck
domain-containing complexes (1LCJ [13], 1LCK [14], 1LKK and 1LKL
[48]), a p85α SH2 domain-containing complex (1PIC [9]), a Cγ1 Syk
SH2 domain-containing complex (2PLD [48]), a Shc PTB domain-con-
taining complex (1SHC [56]), a Shc SH2 domain-containing complex
(1TCE [49]), and a Grb2 SH2 domain-containing complex (1TZE [55]).
A subset of these structures with available binding energies (or dissoci-
ation constants) was used to adjust the binding parameters and is
shown in Table 1. X11 protein [21] was excluded because of its incom-
plete structure in the PDB. The last three complexes were used for
control purposes only, because only the relative binding energies deter-
mined through competitive assays are available. Where IC50 or similar
parameters are used to derive the binding energies, the conversion to
relative binding energies ∆∆Gij for two ligands i and j bound to an identi-
cal receptor was performed as follows (derived from [61]):
∆∆Gij = RT log(IC50i/IC50j) (2)
Where R is the gas constant and T is room temperature.
Model building and refinement
Models of all complexes were regularized and energy minimized. The
regularization procedure builds a full-atom model with idealized cova-
lent geometry as close to the initial Cartesian coordinates of the corre-
sponding PDB entries as possible and has been described elsewhere
[44]. The Cα rmsd for the models were less than 0.5 Å with respect to
their PDB structures. Internal coordinates (bond length, bond angle,
torsion angle and phase angle) were used to describe both the recep-
tors and the ligands, and six virtual variables were associated with the
orientation of each ligand with respect to its receptor. Partial atomic
charges of the phosphate atoms were assigned according to the
widely parameterized Merck molecular force field 94 (MMFF94) [62];
the phosphorous atom carries partial charge of +1.37, whereas each of
the three oxygen atoms carries a partial charge of –1.03.
The refinement procedure, as described in previous flexible docking
studies [44,46], was applied to the initial models. The optimal-bias
Monte Carlo minimization procedure [38] was applied to sample the
sidechain χ angles at the ligand–receptor interface, defined as the
atoms within 10 Å from the shared boundary. Torsion angles of the
ligand (ϕ, ψ) were not globally sampled, but relaxed by local minimiza-
tion after each conformational change. A stack of 40 conformations
was used to keep track of the lowest conformations and to guide the
simulation process [63]. A constant temperature of 700K was used in
the Metropolis criterion. Loose distance restraints (defined in [44])
between the selected ligand–receptor Cα atom pairs were imposed to
prevent the ligand from moving away from the binding site during
refinement. Additional restraints were also assigned to Cβ atoms in the
models built for a Cγ1 Syk domain containing complex [45], a c-
Src/YEEI complex [8], a Shc SH2 domain containing complex [49],
and a Shc PTB domain containing complex [56] in order to keep tyro-
sine aromatic rings in the binding pockets. The ECEPP/3 [64–66]
force field was used for the refinement, and the calculation for each
model took about 7 CPU hours on a 195 MHz MIPS R10000 chip
(~200,000 functional calls).
The above sidechain refinement procedure has previously been suc-
cessfully applied to the simulation of two GCN4 helices [44], as well as
the uncomplexed lysozyme and HyHel5 antibody [58] and β-lactamase
and its inhibitor [41,67]. 
Binding free energy evaluation
The binding energy ∆G is the change in free energies when two mole-
cules associate. Here the free energy of the complex was calculated
with its lowest energy conformation instead of its conformational
ensemble, a technique known as the ‘predominant-states approxima-
tion’ [68]. Free energies of the isolated receptor and ligand were evalu-
ated using the bound conformations of the two molecules, but the
entropy term was added according to the estimated number of free
variables. It was also assumed that the van der Waals interactions at
the complex interface could be estimated as proportional to the surface
buried upon interaction, because of the low accuracy of its explicit eval-
uation. Therefore, the van der Waals contribution was taken into
account by changing the surface energy density due to the solvation
effect. This approximated binding energy can be presented as:
∆Gcalc = ∆GBEP(ε) + s∆A – T∆S + C (3)
where ∆GBEP is the electrostatic contribution, s is the surface tension,
∆A denotes the buried surface area, –T∆S is an entropy contribution
associated with ligand sidechains and backbone, ε is the dielectric
constant of the solute and C is a constant compensating the lost of
translational and rotational entropies of a ligand after association, as
well as other relatively constant contributions unaccounted for in (3).
∆GBEP was calculated by solving the Poisson equation with a rapid-
exact-boundary element (REBEL) method [50]. Hydrophobic effects,
van der Waals interactions and other interface related contributions
were modeled by multiplication of a surface tension constant s to the
change of solvent-accessible surface area. The surface was con-
structed by rolling a probe of 1.4 Å in radius over the all-atom model.
We used the following van der Waals radii: H, 1 Å; C, 1.6 Å; O, 1.35 Å;
N, 1.45 Å. The sidechain entropy calculation was described previously
[38], and the backbone entropy was calculated by multiplying the
number of ligand backbone torsion angles by 0.5 kcal/mol.
Ab initio ligand docking simulation by grid potentials
The grid potentials were calculated in a box placed around the recep-
tor-binding pocket. The box dimensions were approximately
40 Å × 40 Å × 40 Å and the grid size was 0.5 Å. Four different poten-
tials, including electrostatic grid potential, van der Waals grid poten-
tials for hydrogen and heavy atom probes, and hydrogen-bonding
potential, were calculated for each point. The partial charges were
taken from the ECEPP/3 force field [64–66]. All free torsion angles of
docked peptides were randomized with the amplitude of 180° to gen-
erate a starting conformation. A tether with the strength of 1 kcal/Å1/2
was assigned between the phosphorus atom of the phosphate ring and
the binding pocket to reduce sampling space. Peptide conformations
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were sampled with the OBMCM protocol [38] for 3 × 106 functional
calls (~10 CPU hours on a 195 MHz R10000 processor). The lowest
40 conformations accumulated were then subjected to the refinement
process described above. After 20,000 functional calls for each solu-
tion, the 40 candidates were reordered by the more realistic ECEPP/3
force field. A successful prediction was expected to be able to identify
the native conformation among the few lowest energy candidates. The
rmsd, defined as the root mean square deviation of two ligand back-
bone coordinates without optimal superimposition, was used as the cri-
terion for the quality of predicted ligand conformations.
Acknowledgements
We thank the NIH (Grant R01 GM55418-01) and DOE (Grant DE-FG02-
96ER62268) for financial support (this does not constitute an endorsement
by either agency of the views expressed in the article). We are grateful to
Mingming Zhou and Gabriel Waksman for their helpful suggestions. We
also thank Alex Morrill for careful reading of the manuscript.
References
1. Kuriyan, J. & Cowburn, D. (1997). Modular peptide recognition domains
in eukaryotic signaling. Annu. Rev. Biophys. Biomol. Struct. 26, 259-88.
2. Pawson, T. & Schlessinger, J. (1993). SH2 and SH3 domains. Curr.
Biol. 3, 434-442. 
3. Cantley, L.C., et al., & Soltoff, S. (1991). Oncogenes and signal
transduction. Cell 64, 281-302.
4. Margolis, B. (1996). The PI/PTB domain: a new protein interaction
domain involved in growth factor receptor signaling. J. Lab. Clin. Med.
128, 235-241.
5. Zhou, M.M. & Fesik, S.W. (1995). Structure and function of the
phosphotyrosine binding (PTB) domain. Prog. Biophys. Mol. Biol.
64, 221-235.
6. Kavanaugh, W.M. & Williams, L.T. (1994). An alternative to SH2
domains for binding tyrosine-phosphorylated proteins. Science
266,1862-1865.
7. Waksman, G., et al., & Kuriyan, J. (1992). Crystal structure of the
phosphotyrosine recognition domain SH2 of v-src complexed with
tyrosine-phosphorylated peptides. Nature 358, 646-653.
8. Gilmer, T., et al., & Berman, J. (1994). Peptide inhibitors of src SH3–
SH2–phosphoprotein interactions, J. Biol. Chem. 269, 31711-31719.
9. Breeze, L., et al., & Cartlidge, S.A. (1996). Structure of a specific
peptide complex of the carboxy-terminal SH2 domain from the p85α
subunit of phosphatidynositol 3-kinase. EMBO. J. 15, 3579-3589.
10. Panayotou, G., et al., & Waterfield, M.D. (1993). Interactions between
SH2 domains and tyrosine-phosphorylated platelet-derived growth
factor β-receptor sequences: analysis of kinetic parameters by a novel
biosensor-based approach. Mol. Cell. Biol. 13, 3567-3576.
11. Piccione, E., et al., & Shoelson, S.E. (1993). Phosphatidylinositol
3-kinase p85 SH2 domain specificity defined by direct
phosphopeptide/SH2 domain binding. Biochem. 13, 3197-3202.
12. Narula, S.S., et al., & Dalgarno, D.C. (1995). Solution structure of the
C-terminal SH2 domain of the human tyrosine kinase Syk complexed
with a phosphotyrosine peptapeptide. Structure 3, 1061-1073.
13. Eck, M.J., Shoelson, S.E. & Harrison, S.C. (1993). Recognition of a
high-affinity phophotyrosyl peptide by the Src homology-2 domain of
p56lck. Nature 362, 87-91.
14. Eck, M.J., Atwell, S.K., Shoelson, S.E. & Harrison, S.C. (1994).
Structure of the regulatory domains of the Src-family tyrosine kinase
Lck. Nature 368, 764-769.
15. Payne, G., Shoelson, S.E., Gish, G.D., Pawson, T. & Walsh, C.T. (1993).
Kinetics of p56lck and p60src homology 2 domain binding to tyrosine-
phosphorylated peptides determined by a competition assay or surface
plasmon resonance. Proc. Natl Acad. Sci. USA 90, 4902-4906.
16. Sicheri, F., Moarefi, I. & Kuriyan, J. (1997). Crystal structure of the Src
family tyrosine kinase Hck. Nature 385, 602-609.
17. Ladbury, J.E., Lemmon, M.A., Zhou, M., Creen, J., Botfield, M.C. &
Schlessinger, J. (1995). Measurement of the binding of tyrosyl
phosphopeptides to SH2 domains: a reappraisal. Proc. Natl Acad.
Sci. USA 92, 3199-3203.
18. Felder, S., et al., & Schlessinger, J. (1993). SH2 domain exhibit high-
affinity binding to tyrosine phosphorylated peptides yet also exhibit
rapid dissociation and exchange. Mol. Cell Biol. 13, 1449-1455.
19. Zhou, M.M., et al., & Fesik, S.W. (1995). Binding affinities of tyrosine-
phosphorylated peptides to the COOH-terminal SH2 and NH2-
terminal phosphotyrosine binding domains of Shc. J. Biol. Chem.
270, 31119-31123.
20. Zhou, M.M., et al., & Fesik, S.W. (1996). Structural basis for IL-4
receptor phosphopeptide recognition by the IRS-1 PTB domain. Nat.
Struct. Biol. 3, 388-393.
21. Zhang, Z., et al., & Kuriyan., J. (1997). Sequence-specific recognition
of the interalizaiton motif of the Alzheimer’s amyloid precursor protein
by the X11 PTB domain. EMBO J. 16, 6141-6150.
22. Lee, C.H., et al., & Kuriyan, J. (1994). Crystal structures of peptide
complexes of the amino-terminal SH2 domain of the Syp tyrosine
phosphatase. Structure 2, 423-438.
23. Bradshaw, J.M., Grucza, R.A., Ladbury, J.E. & Waksman, G. (1998).
Probing the ‘two-pronged plug two-holed socket’ model for the
mechanism of binding of the Src SH2 domain to phosphotyrosyl
peptides: a thermodynamic study. Biochemistry 37, 9083-9090.
24. Timms, D. & Wilkinson, A.J. (1997). Estimation of binding affinity in
structure-based design. In Computer Simulation of Biomolecular
Systems: Theoretical and Experimental Applications, Volume 3, (van
Gunsteren, W.F., Weiner, P.K. & Wilkinson, A.J., ed.), pp. 466-493,
Kluwer Academic Publishers, Boston. 
25. Ajay & Murcko, M.A. (1995). Computational methods to predict binding
energy in ligand-receptor complexes. J. Med. Chem. 38, 4953-4967.
26. Kollman, P.A. (1994). Theory of macromolecule–ligand interactions,
Curr. Opin. Struct. Biol. 4, 240-245.
27. Lesyng, B. & McCammon, J.A. (1993). Molecular modeling
methods:basic techniques and challenging problems. Pharmacol.
Ther. 60:149-167.
28. Bash, P.A., Singh, U.C., Langridge, R. & Kollman, P.A. (1987). Free
energy calculations by computer simulation. Science 236, 564-568.
29. Muegge, I., Schweins, T. & Warshel, A. (1998). Electrostatic
contributions to protein-protein binding affinities: application to
Rap/Raf interaction. Proteins 30, 407-423.
30. Vajda, S., Sippl, M. & Novotny, J. (1997). Empirical potentials and
functions for protein folding and binding. Curr. Opin. Struct. Biol.
7, 222-228.
31. Rosenfeld, R., Vajda, S. & DeLisi, C. (1995). Flexible docking and
design. Annu. Rev. Biophys. Biomol. Struct. 24, 677-700.
32. Horton, N. & Lewis, M. (1992). Calculation of the free energy of
association for protein complexes. Protein Sci. 1, 169-181.
33. Novotny, J., Bruccoleri, R.E. & Saul, F.A. (1989). The attribution of
binding energy in antigen-antibody complexes McPC 603, D1.3,
HyHEL-5. Biochemistry 28, 4735-4749.
34. Novotny, J., Bruccoleri, R.E., Davis, M. & Sharp, K.A. (1997). Empirical
free energy calculations: a blind test and futher improvements to the
method. J. Mol. Biol. 268, 401-411.
35. Chothia, C. & Janin, J. (1975). Principles of protein–protein
recognition. Science 256, 705-708.
36. Kuntz, I.D. (1992). Structure-based strategies for drug design and
discovery. Science 257, 1078-1082.
37. Krystek, S., Stouch, T. & Novotny, J. (1993). Affinity and specificity of
serine endopeptidase-protein inhibitor interactions: empirical free
energy calculations based on X-ray crystallographic structures. J. Mol.
Biol. 234, 661-679.
38. Abagyan, R.A. & Totrov, M.M. (1994). Biased probability Monte Carlo
conformational searches and electrostatic calculations for peptides
and proteins. J. Mol. Biol. 235, 983-1002.
39. Lengauer. T. & Rarey, M. (1996). Computational methods for
biomolecular docking. Curr. Opin. Struct. Biol. 6, 402-406.
40. Shoichet, B. & Kuntz, I.D. (1996). Predicting the structure of protein
complexes: a step in the right direction. Chem. Biol. 3, 151-156.
41. Janin, J. (1995). Protein–protein recognition. Prog. Biophys. Molec.
Biol. 64, 145-166.
42. Gulukota, K., Vajda, S. & DeLisi, C. (1996). Peptide docking using
dynamic programming. J. Comp. Chem. 17, 418-428.
43. Abagyan, R.A. (1997). Protein structure prediction by global energy
optimization. In Computer Simulation of Biomolecular Systems:
Theoretical and Experimental Applications, Volume 3, (van Gunsteren,
W.F., Weiner, P.K. & Wilkinson, A.J., ed.), pp.363-394, Kluwer
Academic Publishers, Boston. 
44. Abagyan, R.A., Totrov, M.M. & Kuznetsov, D.N. (1994). ICM — a new
method for protein modeling and design. Applications to docking and
structure prediction from the distorted native conformation. J. Comp.
Chem. 15, 488-506.
45. Luty, B.A., Wasserman, Z.R., Stouten, P.F.W. & Hodge, D.N. (1995).
A molecular mechanics/grid method for evaluation of ligand–receptor
interactions. J. Comp. Chem. 16, 454-464.
46. Totrov, M.M. & Abagyan, R.A. (1997). Flexible protein–ligand docking
by global energy optimization in internal coordinates. Proteins
(suppl 1), 215-220.
Research Paper Phosphotyrosine binding to SH2 and PTB Zhou and Abagyan    521
47. Tong, L., Warren, T.C., King, J., Betageri, R., Rose, J. & Jakes, S.
(1996). Crystal structures of the human p56lck SH2 domain in
complex with two short phophotyrosyl peptides at 1.0 Å and 1.8 Å
resolution. J. Mol. Biol. 256, 601-610.
48. Pascal, S.M., et al., & Forman-Kay J.D. (1994). Nuclear magnetic
resonance structure of an SH2 domain of phospholipase C-γ1
complexed with a high affinity binding peptide. Cell 77, 461-472.
49. Zhou, M., et al., & Fesik, S.W. (1995). Solution structure of the shc
SH2 domain complexed with a tyrosine-phosphorylated peptide from
the T-cell receptor. Proc. Natl Acad. Sci. USA 92, 7784-7788.
50. Gilson, M.K. (1997). Modeling protonation equilibria in
biomolecules. In Computer Simulation of Biomolecular Systems:
Theoretical and Experimental Applications, Volume 3. (van
Gunsteren, W.F., Weiner, P.K. & Wilkinson, A.J., ed.), pp.199-222,
Kluwer Academic Publishers, Boston. 
51. Bradshaw, J. & Waksman, G. (1998). A calorimetric investigation of
proton linkage by monitoring both the enthalpy and association
constant of binding: application to the interaction of the Src SH2
domain with a high affinity tyrosyl phosphopeptide. Biochemistry
37, 15400-15407.
52. Totrov, M.M. & Abagyan, R.A. (1996). The contour-buildup algorithm to
calculate the analytical molecular surface. J. Struct. Biol. 116, 138-143.
53. Tunon, I., Silla, E., Pascual-Ahuir, J.L. (1992). Molecular surface area
and hydrophobic effect. Protein Eng. 5, 715-716.
54. Wesson, L. & Eisenberg, D. (1992). Atomic solvation parameters applied
to molecular dynamics of proteins in solution. Protein Sci. 1, 227-235.
55. Rahuel, J., et al., & Grutter, M.G. (1996). Structural basis for
specificity of Grb2-SH2 revealed by a novel ligand binding mode. Nat.
Struct. Biol. 3, 586-589. 
56. Zhou, M., et al., & Feslk, S.W. (1995). Structure and ligand recognition
of the phosphotyrosine binding domain of shc. Nature 378, 584-592.
57. Waksman, G., Shoelson, S.E., Pant, N., Cowburn, D. & Kuriyan J.
(1993). Binding of a high affinity phosphotyrosyl peptide to the Src
SH2 domain: crystal structures of the complexed and peptide-free
forms. Cell 72, 770-790.
58. Totrov, M.M. & Abagyan, R.A. (1994). Detailed ab initio prediction of
lysozyme-antibody complex with 1.6 Å accuracy. Nat. Struct. Biol.
1, 259 -263.
59. Caflisch, A., Niederer, P. & Anliker, M. (1992). Monte Carlo docking of
oligopeptides to proteins. Proteins 13, 223-230.
60. Xu, R.X., Word, J.M., Davis, D.G., Rink, M.J., Willard, D.H., Jr. &
Gampe, R.T., Jr. (1995). Solution structure of the human pp60 c-src
sh2 domain complexed with a phosphorylated tyrosine pentapeptide.
Biochemistry 34, 2107-2121.
61. Pratt, W.B. Taylor, P. (1990). Principle of drug action: the basis of
pharmacology, (3rd edn), Churchill Livingstone, New York.
62. Halgren, T.A. (1992). Merck Molecular Force Field. I-V. J. Comp.
Chem. 17, 1995, 490-641.
63. Abagyan, R.A. & Argos, P. (1992). Optimal protocol and trajectory
visualization for conformational searches of peptides and proteins.
J. Mol. Biol. 225, 519-532.
64. Momany, F.A., McGuire, R.F., Burgess, A.W. & Scheraga, H.A. (1975).
Energy parameters in polypeptides. VII. Geometric parameters, partial
atomic charges, nonbonded interactions, hydrogen bond interactions
and intrinsic torsional potentials for the naturally occurring amino
acids. J. Phys. Chem. 79, 2361-2381.
65. Nemethy, G., Pottle, M.S. & Scheraga, H.A. (1983). Energy
parameters in polypeptides. IX. Updating of geometric parameters,
nonbonded interactions and hydrogen bond interactions for the
naturally occurring amino acid. J. Phys. Chem. 87, 1883-1887. 
66. Nemethy, G., et al., & Scheraga, H.A. (1992). Energy parameters in
polypeptides. 10. Improved geometric parameters and nonbonded
interactions for use in the ECEPP/3 algorithm, with application to
proline-containing peptides. J. Phys. Chem. 96, 6472-6484.
67. Strynadka, N.C.J., et al., & James, (1996). M.N.G. Molecular docking
programs successfully determine the binding of a β-lactamase
inhibitory protein to term-1 β-lactamase. Nat. Struct. Biol. 3, 233-239.
68. Gilson, M.K., Given, J.A. & Head, M.S. (1997). A new class of models
for computing receptor–ligand binding affinities. Chem. Biol. 4, 87-92.
69. Lemmon, M.A. & Ladbury, J.E. (1994). Thermodynamic studies of
tyrosyl-phosphopeptide binding to the SH2 domain of p56lck.
Biochemistry 33, 5070-5076.
70. Case, R.D., et al., & Shoelson, S.E. (1994). SH-PTP2 SH2 domain
binding specificity is defined by direct interactions with platelet-growth
factor beta-receptor, epidermal growth factor receptor, and insulin
receptor substrate-1-derived phosphopeptide. J. Biol. Chem. 269,
10467-10474.
522 Folding & Design Vol 3 No 6
Because Folding & Design operates a ‘Continuous Publication
System’ for Research Papers, this paper has been published
on the internet before being printed. The paper can be
accessed from http://biomednet.com/cbiology/fad — for
further information, see the explanation on the contents pages.
